See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days
News Digest / StockInvest.us

Author: StockInvest.us
07:03am, Monday, Aug 11, 2025
Cadrenal pushes tecarfarin into ESKD trials as cash burn, rising G&A heighten financing risk
Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) - Quick internal read Management is advancing tecarfarin into late-stage clinical activity (announced trial plans for ESKD patients on August 5, 2025) while burning cash to support operations and public-company overhead. The company used its ATM program ...
C
Read More